Key Takeaways
- • Getfive Funds received SEBI approval to launch its second alternative investment fund, Getfive Opportunity Fund II, a proposed Category I AIF with a corpus of ₹500 crore, according to the company's October 14, 2026 announcement.
- • The fund will invest in emerging SMEs across Tier 1, Tier 2 and Tier 3 Indian markets, spanning manufacturing, defence, aerospace, deep-tech, healthcare, pharmaceuticals, financial services, agritech, logistics and renewable energy.
- • The first Getfive opportunity fund has a target size of ₹100 crore and has raised around ₹61 crore so far, per the company.
- • Managing director Shrikant Goyal expects around 400 SME companies to list on BSE SME and NSE Emerge over the next three to four years, a company estimate.
- • The second fund will follow a growth-investing approach that assesses promoters, business fundamentals and industry prospects.
Summary
Getfive Funds has received approval from the Securities and Exchange Board of India (SEBI) to launch its second alternative investment fund, according to the company's statement on October 14, 2026. The proposed Category I AIF, Getfive Opportunity Fund II, carries a target corpus of ₹500 crore and will direct capital toward small and medium enterprises (SMEs).
The fund will target emerging companies across Tier 1, Tier 2 and Tier 3 markets in India. Its investment focus spans manufacturing, defence, aerospace, deep-tech, healthcare, pharmaceuticals, financial services, agritech, logistics and renewable energy. Getfive said the fund will follow a growth-investing strategy, evaluating companies on the strength of their promoters, business fundamentals and industry prospects.
The second fund builds on the company's first opportunity fund, which has a target size of ₹100 crore and has raised around ₹61 crore to date, according to Getfive. Getfive operates in merchant banking and alternative investment management, and its first opportunity fund is registered as a Category I AIF under SEBI's venture capital fund category.
Shrikant Goyal, managing director of Getfive Funds, advised investors in SME companies to assess business fundamentals, promoter track records, balance sheets, valuations and scalability rather than decide based on listing-day gains or market trends. Goyal also said the company expects around 400 SME companies to list on the BSE SME and NSE Emerge platforms over the next three to four years, describing this as the company's own estimate.
The company noted that SME investments carry significant risks, including lower liquidity, limited financial disclosures compared with larger listed companies and sharp price fluctuations.
The fund will target emerging companies across Tier 1, Tier 2 and Tier 3 markets in India. Its investment focus spans manufacturing, defence, aerospace, deep-tech, healthcare, pharmaceuticals, financial services, agritech, logistics and renewable energy. Getfive said the fund will follow a growth-investing strategy, evaluating companies on the strength of their promoters, business fundamentals and industry prospects.
The second fund builds on the company's first opportunity fund, which has a target size of ₹100 crore and has raised around ₹61 crore to date, according to Getfive. Getfive operates in merchant banking and alternative investment management, and its first opportunity fund is registered as a Category I AIF under SEBI's venture capital fund category.
Shrikant Goyal, managing director of Getfive Funds, advised investors in SME companies to assess business fundamentals, promoter track records, balance sheets, valuations and scalability rather than decide based on listing-day gains or market trends. Goyal also said the company expects around 400 SME companies to list on the BSE SME and NSE Emerge platforms over the next three to four years, describing this as the company's own estimate.
The company noted that SME investments carry significant risks, including lower liquidity, limited financial disclosures compared with larger listed companies and sharp price fluctuations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.